News
Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.
A single mum has shared the incredibly subtle sign of her skin cancer that struck twice, and resulted in a 'big gaping black ...
"The sun is lethal. You don't need to be tanned to be beautiful either, so what if you're pale?" Andrew Lines, 70, from ...
11d
News-Medical.Net on MSNMutation profiles and clinicopathological correlations in lung squamous cell carcinomaLung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified ...
“Libtayo is the first medicine to demonstrate a statistically significant benefit in patients who have high-risk features for recurrence after resection of cutaneous squamous cell carcinoma and ...
10d
Sportschosun on MSNA pimple on my nose. I thought it was a pimple…Skin cancer diagnosis twice in 3 yearsA British woman in her 30s was diagnosed with skin cancer after considering a pimple on her nose. Kerry Ann Buckell, 35, from ...
3d
Salisbury Journal on MSNCancer patient grateful for 'life-changing' new equipment funded by Stars AppealThe six scopes cost £115,000, and the fund was provided by the Stars Appeal, the charity for Salisbury District Hospital.
"While surgery and radiotherapy remain the cornerstones of treatment for high-risk cutaneous squamous cell carcinoma, there is a critical unmet need for systemic therapies to help prevent relapse and ...
Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results